CDH10 and breast cancer: To assess whether changes in CDH10 protein levels are at least partially responsible for the motility phenotype observed in breast cancer cells in hypoxia, CDH10 was overexpressed in MDA-MB-231 cells and motility was examined in normoxic and hypoxic conditions.